Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression

E-ISSN： 1875-533x|18|36|5507-5518

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.36, 2011-12, pp. : 5507-5518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostatic Tumor Stroma: A Key Player in Cancer Progression

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 490-497

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell Immunotherapy for Acute Inflammatory Diseases

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 2, 2007-05 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 195-212

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Mediators in Inflammatory Disorders

By Heller A.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 487-496

Adis International

Access to resources Recommend Favorite

Role of Inflammatory Mediators in Angiogenesis

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite